White label ELPA - ClinicalTrials.eu

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Not recruiting

3 1 1
Investigated diseases:
- Squamous cell carcinoma
Investigated drugs:
- Pembrolizumab
+5
Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Not recruiting

3 1 1
Investigated diseases:
- Renal cell carcinoma
Investigated drugs:
- Pembrolizumab
- Sodium Chloride
+3
Study on Calcium Folinate to Reduce Pemetrexed Side Effects in Patients with Non-Small Cell Lung Cancer, Mesothelioma, or Thymoma

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Calcium Folinate
Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Not recruiting

2 1 1
Investigated diseases:
- Anaemia
- Myelodysplastic syndrome
Investigated drugs:
- Ag-946
+2
Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Not recruiting

2 1
Investigated diseases:
- Pulmonary hypertension
Investigated drugs:
- 3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid
Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Not recruiting

3 1 1 1
Investigated diseases:
- Hepatitis D
Investigated drugs:
- Bulevirtide
+1
Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Not recruiting

2 1
Investigated diseases:
- Lipoprotein metabolism disorder
Investigated drugs:
- Ly3819469 Sodium
Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Not recruiting

2 1 1 1
Investigated diseases:
- Autoimmune haemolytic anaemia
- Neoplasm malignant
Investigated drugs:
+2
Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Gen1053
Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated drugs:
- Pembrolizumab
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies